known
contactdepend
signal
involv
actual
celltocel
contact
exchang
cytoplasm
materi
nanotub
gap
junction
exemplifi
notch
signal
pathway
paracrin
signal
refer
signal
effect
releas
molecul
close
proxim
sourceproduc
cell
final
endocrin
signal
protein
molecul
produc
cell
transport
system
blood
stream
act
distal
may
act
either
gener
mani
cell
specif
select
recipi
cell
contain
appropri
molecular
characterist
ie
correct
receptor
etc
function
proteinbas
signal
cue
gener
triphas
involv
bind
cell
surfac
receptor
ii
intern
cell
iii
downstream
signal
translat
measur
respons
cell
contrast
wellstudi
protein
base
celltocel
signal
discuss
possibl
rna
ribonucl
acid
base
celltocel
signal
come
forefront
recent
result
discoveri
cellextrud
membran
bioactiv
vesicl
call
exosom
transfer
function
protein
rna
speci
one
cell
anoth
result
chang
recipi
cell
properti
exosom
may
rich
sourc
stabl
reproduc
biomark
varieti
condit
present
review
provid
brief
descript
biogenesi
molecular
properti
exosom
establish
date
review
studi
implic
function
activ
exosom
model
system
final
review
biomark
potenti
exosom
respect
solubleaccess
biomark
cell
secret
varieti
small
defin
vesicl
various
term
exosom
microparticl
microvesicl
apoptot
bleb
gener
remain
state
ambigu
regard
classif
particl
categori
term
often
use
interchang
classif
particl
strictli
exosom
base
primarili
size
densiti
membran
composit
presenc
late
endosom
compon
like
alix
tumor
suscept
gene
tetraspanin
reveal
multivesicular
bodi
mvb
origin
exosom
exosom
first
describ
exfoli
monolay
cultur
contain
ectoatpas
adenosin
triphosphatas
exonucleas
activ
suggest
deriv
specif
subdomain
plasma
membran
earli
research
johnston
et
al
establish
fig
exosom
contain
divers
type
protein
mrna
mirna
figur
show
exosom
content
exosom
deriv
mous
cell
exocarta
compendium
queri
exosom
studi
protein
mrna
mirna
content
record
sampl
consid
larg
number
entiti
consid
protein
rna
part
top
physiolog
function
group
ingenu
pathway
analysi
use
cluster
protein
molecular
categori
subcellular
local
function
group
diagram
top
right
panel
indic
subcellular
local
exosom
protein
mrna
repres
protein
may
encod
mrna
function
get
translat
symbol
legend
indic
figur
top
function
cluster
protein
b
mirna
c
mrna
c
graphic
depict
data
repres
top
hit
ingenu
gener
canon
pathway
analysi
function
protein
cluster
accord
recent
report
exosom
also
contain
mitochondri
dna
oncogenicamplifi
dna
microvesicl
help
matur
erythrocyt
get
rid
transferrin
receptor
obsolet
protein
visual
electron
microscopi
correl
vesicl
releas
kinet
well
establish
endocytosi
kinet
marker
transferrin
receptor
tfr
reveal
subset
endosom
vesicl
releas
intact
cell
exterior
mechan
distinct
endocyt
recycl
process
involv
invagin
limit
membran
form
structur
bud
lumen
late
endosom
exosom
known
encapsul
materi
cell
cytoplasm
includ
rna
protein
dna
deoxyribonucl
acid
fig
two
membran
invers
occur
format
exosom
membran
patch
plasma
membran
two
membran
invers
allow
exosom
present
tran
membran
cargo
orient
rel
cytoplasm
plasma
membran
one
invers
occur
plasma
membran
endocyt
intern
plasma
membran
invagin
prior
bud
second
invers
occur
intralumin
vesicl
ilv
bud
lumen
late
endosom
fig
rather
direct
lysosom
compart
fate
well
character
branch
late
endosom
mvb
popul
fusion
multivesicular
bodi
plasma
membran
releas
exosom
extracellular
space
process
direct
transport
reli
sever
compon
endocyt
machineri
rab
gtpase
rasrel
brain
rab
rab
b
cytoskeleton
regulatori
protein
molecular
motor
myosin
snare
snap
solubl
nsf
attach
protein
receptor
target
fusion
fig
cell
hematopoiet
lineag
bcell
dendrit
cell
mast
cell
tcell
platelet
initi
character
exosom
product
later
year
nonhematopoiet
cell
variou
epitheli
cell
type
neuron
wide
varieti
tumor
cell
also
shown
produc
exosom
particular
interest
tumor
cell
exhibit
enhanc
product
exosom
mechan
need
enhanc
product
exosom
understood
may
indic
role
exosom
tumor
develop
sinc
exosom
product
continu
cell
function
certain
cell
type
like
platelet
treat
agonist
induc
degranul
enhanc
releas
microvesicl
exosom
exosom
secret
also
increas
free
radic
stress
uv
irradi
decreas
membran
cholesterol
increas
intracellular
calcium
vivo
exosom
character
circul
bodi
fluid
plasma
urin
saliva
broncheoalveolar
lavag
bal
cerebrospin
fluid
csf
other
biogenesi
molecular
relev
exosom
exosom
aris
cell
endosom
system
plasma
membran
invagin
bud
endocyt
intern
cargo
destin
lysosom
degrad
ubiquitin
earli
endosom
decis
recycl
direct
late
endosom
reli
specif
protein
interact
domain
base
sort
earli
endosom
matur
late
endosom
compart
inward
bud
intralumen
vesicl
ilv
allow
captur
cytoplasm
cargo
distinct
subset
ilv
may
target
cargo
lysosom
degrad
escrt
depend
ceramid
independ
releas
cargo
cell
exterior
via
exosom
format
exosom
ceramid
biosynthesi
depend
rel
escrt
independ
exosom
retain
similar
membran
topolog
plasma
membran
due
two
membran
invers
event
sort
cargo
exosom
reli
specif
interact
lipid
protein
membran
subdomain
well
interact
tetraspanin
web
b
exosom
intern
cell
close
donor
origin
cell
juxtacrin
uptak
distanc
donor
cell
paracrin
uptak
may
spread
system
circul
taken
distant
tissu
endocrin
uptak
specif
exosom
uptak
function
recipi
cell
lineag
exosom
surfac
marker
host
cell
surfac
marker
contribut
select
uptak
exosom
may
begin
protein
base
signal
function
even
adher
host
cell
uptak
exosom
occur
primarili
phagolysosom
intermedi
util
specif
receptor
exosom
surfac
protein
receptor
intern
exosom
content
releas
via
phagolysosom
local
late
endosom
c
exosom
lipid
protein
rna
mirna
dna
content
alter
recipi
cell
molecular
profil
variou
mechan
alter
gene
express
possibl
exosom
cargo
mediat
recipi
cell
reprogram
may
includ
alter
transcript
translat
profil
transcript
protein
modif
regul
signal
cascad
protein
local
turnaround
key
enzymat
reaction
cellular
homeostasi
sourc
condit
donor
recipi
cell
may
determin
molecular
mechan
predomin
intriguingli
exosom
may
also
recipi
cell
type
specif
function
molecul
ee
earli
endosom
mvb
multivesicular
bodi
le
late
endosom
ilv
intralumin
vesicl
recycl
endosom
rab
ra
superfamili
gtpase
escrt
endosom
sort
complex
requir
transport
exosom
differ
sourc
common
core
set
protein
help
character
endosomederiv
cellular
vesicl
extent
common
mrna
mirna
content
well
establish
due
limit
number
global
studi
profil
speci
onlin
resourc
exist
exocarta
compendium
exosom
base
studi
compil
protein
mrna
mirna
data
differ
sourc
searchabl
format
addit
urinari
exosom
resourc
knepper
lab
nih
also
provid
detail
dataset
urin
exosom
protein
content
urinari
exosom
protein
databas
augment
core
set
compon
biolog
exosom
origin
cell
type
cell
condit
specif
cargo
protein
lipid
rna
mirna
dna
fig
depend
biomolecular
content
cell
context
variat
normal
diseas
cell
garner
much
interest
exosom
harbor
diseas
biomark
could
thought
fluidom
liquid
biopsi
extract
exosom
bodi
fluid
provid
snapshot
donor
cell
condit
result
obtain
biomark
studi
date
prompt
author
suggest
exosom
miniatur
cell
term
healthi
vs
normal
statu
exosom
aris
within
cellular
endosom
compart
reason
presum
cytoplasm
cargo
must
repres
exosom
exemplifi
presenc
membran
marker
exosom
like
alix
involv
mvb
biogenesi
mono
ubiquitin
cargo
sort
lysosom
degrad
mvb
wellstudi
process
mvb
topolog
serv
sort
station
ubiquitin
cargo
direct
ilv
fate
degrad
membran
sequestr
allow
protein
direct
recycl
compart
endosom
cargo
rerout
recycl
fate
deliv
exosom
later
segreg
membran
gpianchor
lipidraft
enrich
microdomain
antibodi
mediat
higher
order
oligomer
via
aggreg
fig
protein
undergo
recycl
exosom
contain
fate
depend
bind
partner
exampl
reticulocyt
matur
decreas
clathrin
adaptor
level
caus
transferrin
receptor
associ
heat
shock
cognat
protein
alix
rather
bind
highlight
intricaci
molecular
balanc
bind
motif
util
interact
remain
signific
gap
understand
mechan
allow
rerout
protein
possibl
entir
ilv
mark
degrad
exosom
releas
exosom
biolog
suggest
exist
separ
subset
mvb
reli
escrtdepend
escrt
endosom
sort
complex
requir
transport
sort
signal
receptor
other
appear
form
primarili
ceramid
synthesi
drive
factor
exosom
format
fig
molecular
mechan
direct
two
process
like
distinct
requir
elucid
one
intrigu
aspect
exosom
biolog
remain
packag
divers
protein
rna
exosom
fig
initi
report
suggest
unlik
exosom
content
simpli
reflect
nonspecif
stoichiometr
abund
protein
rna
throughout
cytoplasm
exampl
studi
skog
et
al
demonstr
glioblastoma
deriv
microvesicl
enrich
rel
unfraction
glioblastoma
cell
sever
protein
mrna
mirna
would
aid
tumor
growth
angiogenesi
cell
cycl
disrupt
control
translat
immun
suppress
similarli
stemnessimpart
characterist
enrich
stemcel
deriv
exosom
demonstr
cell
context
specif
select
exosom
cargo
noteworthi
sever
molecul
adapt
clathrinco
pit
also
found
exosom
suggest
membran
deform
cargo
select
may
util
molecular
machineri
plasma
membran
recent
tetraspanin
protein
implic
exosom
cargo
select
along
provid
mechanist
framework
formul
exosom
interest
note
escrt
complex
implic
exosom
format
also
involv
select
protein
sort
eg
bind
bicoid
rna
escrt
ii
complex
allow
sort
endosom
system
furthermor
recent
report
mvb
system
link
matur
risc
complex
provid
altern
novel
mechan
load
rna
mirna
speci
exosom
recent
studi
indic
subset
plasma
mir
bound
ldl
may
yet
anoth
mechan
allow
load
exosom
like
vesicl
exit
cell
given
varieti
potenti
mechan
exosom
format
exosom
load
remain
clear
need
establish
adaptor
sort
motif
lipidprotein
lipidrna
mirna
rnaprotein
mirnaprotein
proteinmrnamirna
interact
allow
specif
cargo
packag
exosom
origin
exosomesderiv
cancer
cell
line
credit
nucleotidas
atpas
activ
paper
also
suggest
exosom
taken
recipi
cell
exosom
later
describ
sink
dispos
obsolet
protein
transferrin
receptor
acetylcholinesteras
cytochalasin
b
bind
glucos
transport
nucleosid
transport
excess
plasma
membran
reticulocyt
matur
erythrocyt
recent
time
domin
mode
exosom
uptak
recipi
cell
appear
phagocyt
process
depend
phosphatidyl
uptak
process
also
reli
varieti
specif
cell
surfac
molecul
receptor
cell
tcell
membran
protein
shown
involv
exosom
uptak
well
protein
like
integrin
annexin
galectin
intercellular
adhes
molecul
exosom
surfac
uptak
exosom
possibl
nonrandom
event
recent
paper
suggest
mechanist
basi
target
cell
select
invok
tetraspanin
entri
select
marker
support
defin
set
exosomeassoci
tetraspanin
appear
direct
target
endotheli
cell
promot
angiogenesi
vasculogenesi
also
shown
valadi
et
al
dcderiv
exosom
effici
taken
dc
lineag
cell
recent
paper
well
document
evid
exosom
act
system
behav
endocrin
moieti
respect
long
rang
target
tissu
specif
uptak
stabil
exosom
system
circul
yet
anoth
interest
potenti
therapeut
exploit
aspect
exosom
biolog
post
intern
exosom
found
phagolysosom
along
phagocytosisinduc
biospher
found
coloc
late
endosom
compart
indic
may
cell
type
specif
trajectori
recipi
cell
postuptak
fig
mode
releas
exosom
content
cytoplasm
known
although
suggest
exosom
surfac
protein
may
perform
signal
function
host
cell
surfac
adher
cell
intern
releas
exosom
cargo
protein
dna
lipid
mrna
mirna
caus
alter
recipi
cell
similar
cellular
signal
base
respons
system
exosom
global
signal
moieti
signal
cascad
respons
within
cell
fig
rang
molecular
effect
quit
divers
summar
fig
reflect
role
variou
cargo
identifi
exosom
date
upon
host
cell
gene
express
profil
interest
exosom
immun
respons
burgeon
discoveri
antigen
present
cell
apc
enhanc
immun
cell
respons
util
exosom
antigen
present
endosom
apc
enrich
mhc
major
histocompat
complex
class
ii
molecul
mhc
class
iiassoci
chaperon
ii
proteas
requir
ii
degrad
antigen
process
exosom
apc
similarli
enrich
mhc
mhc
ii
immunomodulatori
protein
strong
immunogen
respons
dendrit
cell
dc
exosom
also
known
dexosom
gener
reli
presenc
costimulatori
molecul
apc
howev
case
dexosom
shown
stimul
suffici
immun
respons
depend
sole
mhc
concentr
absenc
apc
correspond
costimulatori
molecul
bcell
deriv
exosom
elicit
immun
respons
direct
antigen
present
tcell
howev
common
mechan
exosomestimul
immun
respons
exosom
interact
directli
tcell
immatur
dendrit
cellderiv
exosom
immatur
dex
idex
induc
indirect
tcell
activ
via
present
mhcantigen
complex
receptor
dc
cd
cluster
differenti
tcell
activ
mhciiantigen
complex
transfer
recipi
dc
similarli
mhciantigen
complex
transfer
dc
aid
polar
tcell
idex
respons
vivo
reli
dc
process
depend
lymphocyt
functionassoci
antigen
exosom
captur
continu
without
exosom
intern
process
respons
requir
administr
dc
matur
agent
like
toll
like
receptor
indic
requir
apc
induc
dex
respons
cytotox
tlymphocyt
target
cell
recognit
induc
rapid
polar
recycl
endosom
well
exosom
process
mediat
vesicl
mobil
necessari
releas
cytotox
granul
addit
immatur
dc
deriv
exosom
may
transfer
process
antigenmhc
complex
dc
thu
increas
effect
number
apc
dc
exosom
dc
mhcantigen
present
common
also
shown
mast
cell
deriv
exosom
peptid
cargo
may
present
surfac
recipi
bcell
dc
term
mechan
induc
immun
respons
recent
report
suggest
exosom
carri
bioactiv
cytokin
exemplifi
presenc
inflammasom
compon
concentr
tumor
necrosi
factor
tnfa
dexosom
indic
addit
role
adapt
immun
exosom
could
also
trigger
innat
immun
respons
fact
mediat
amplif
respons
via
cargo
protein
rna
mirna
transfer
respons
tract
epithelium
continu
intens
amount
research
deriv
find
mani
studi
establish
exosom
content
function
depend
precis
matur
stage
cell
lineag
stimul
state
parent
immun
cell
exampl
immatur
dc
produc
larger
number
mvb
exosom
immatur
dc
howev
level
induc
antigen
specif
tcell
respons
matur
dc
deriv
exosom
show
twice
potenc
immun
function
dcderiv
exosom
tailor
immunogen
toler
depend
presenc
specif
molecular
cargo
increasingli
found
use
creat
highli
special
therapeut
term
design
dexosom
util
cancer
therapi
vaccin
develop
transplant
toler
induct
recent
review
viaud
et
al
exosom
virus
seem
develop
close
associ
prompt
virologist
suggest
coopt
molecular
machineri
evolv
immatur
dc
task
deliv
viral
antigen
peripheri
lymphoid
organ
addit
mechan
significantli
increas
number
viru
challeng
dc
amplif
involv
matur
dc
phagocytos
antigenbear
dc
antigenload
exosom
produc
infect
dc
exosom
antigen
dissemin
pathway
intrins
dc
involv
enrich
function
epitopemhc
complex
exosom
releas
cell
follow
uptak
immun
effector
cell
exosom
packag
system
allow
viru
surviv
within
endocyt
system
without
lysosom
degrad
allow
subsequ
transinfect
tcell
fig
hiv
human
immunodefici
viru
retrovirus
util
dexosom
base
predominantli
mhcii
antigen
complex
present
schema
transinfect
tcell
immatur
dc
exhibit
bud
hiv
structur
becom
exosom
stage
revers
bud
late
endosom
per
particl
basi
exosom
associ
particl
infecti
cellfre
viru
particl
matur
dcintern
viral
particl
need
compet
virionlik
particl
vlp
exosom
vesicl
intern
stage
segreg
lipidraft
like
cholesterol
enrich
micro
domain
dc
glycosphingolipid
exosomeproduc
cell
known
critic
process
vlp
exosom
intern
matur
host
dc
plasma
membran
probabl
occur
facilit
interact
exosom
viral
membran
host
convers
indic
virus
hijack
host
system
surviv
propag
trojan
exosom
hypothesi
propos
envelop
retrovirus
like
hiv
util
host
cell
endosom
system
includ
exosom
pathway
move
apc
search
best
target
cell
fig
well
known
hiv
viral
bud
occur
mhc
iienrich
compart
similar
mvb
gener
ilvsexosom
result
bind
hepatocyt
growth
factor
tyrosin
kinas
substrat
hr
ubiquitin
cargo
follow
recruit
gag
mimic
hr
therebi
usurp
compon
mvb
machineri
order
facilit
viral
bud
similar
exosom
viral
bud
pathway
prompt
compar
studi
indic
virus
disguis
ilv
may
coopt
exosom
pathway
releas
typic
exosom
membran
lipid
composit
allow
propag
without
engag
host
immun
respons
mechan
disguis
propag
viru
also
abl
conserv
resourc
fusion
cell
util
exosom
intern
machineri
enter
host
cell
shown
part
physiolog
role
exosom
abil
alter
microenviron
protein
rna
base
cargo
instanc
studi
tumor
deriv
exosom
reveal
may
perform
sever
function
aid
tumor
surviv
metastasi
fig
presenc
hlag
exosom
secret
melanoma
cell
might
indic
role
creat
tumor
toler
associ
respons
tolerogen
activ
exosom
associ
fasand
trailexpress
exosom
membran
induc
fasland
trailmedi
apoptosi
antitumor
tcell
incub
tumor
deriv
exosom
disrupt
matur
differenti
hladr
lowneg
monocyt
precursor
dc
result
lack
tcell
stimulatori
effect
exosom
cocultur
primarili
due
alter
monocyt
cytokin
profil
exemplifi
inflammatori
cytokin
tnfa
interleukin
proangiogen
immunosuppress
factor
eg
tgfb
support
result
peripher
blood
melanoma
patient
reveal
predict
hladr
lowneg
mhc
class
ii
cell
surfac
receptor
tumor
growth
factor
tgfb
secret
myeloid
cell
popul
absent
healthi
individu
tumor
deriv
exosom
contain
sever
cytokin
growth
factor
tumor
necrosi
factor
tnfa
tgfb
well
function
receptor
like
consequ
tumor
deriv
exosom
natur
support
neoangiogenesi
sinc
enrich
tetraspanin
enhanc
secret
vegf
vascular
endotheli
growth
factor
metalloproteinas
target
cell
strike
result
skog
studi
glioblastoma
deriv
microvesicl
reveal
tumor
deriv
exosom
could
support
cell
cultur
base
angiogenesi
huvec
human
umbil
vein
endotheli
cell
almost
extent
extran
ad
growth
factor
melanoma
exosom
shown
induc
endotheli
cell
spheroid
format
move
endotheli
tubul
cell
use
tunnel
nanotub
structur
act
primarili
paracrin
manner
adenocarcinoma
model
exosom
induc
sever
angiogenesi
relat
gene
includ
von
willebrand
factor
chemokin
cxc
motif
chemokin
mif
macrophag
migrat
inhibitori
factor
chemokin
receptor
indic
involv
vegf
independ
process
exosomemedi
angiogenesi
recent
studi
show
exosom
mutant
kra
allel
bear
cell
line
greater
invas
potenti
exosom
autolog
cell
line
mutant
kra
remov
homolog
recombin
properti
could
clearli
aid
format
premetastat
nich
exosom
also
aid
spread
human
tumor
epstein
barr
viru
ebv
oncogen
protein
call
latent
membran
protein
uninfect
cell
ebv
enrich
exosom
protein
cancer
associ
thu
induc
enhanc
cell
growth
angiogenesi
transform
cell
evad
immun
respons
encapsul
circul
exosom
deliveri
system
exosom
addit
function
mediat
spread
cell
damag
alter
microenviron
variou
metabol
nervou
system
disord
exampl
microenviron
alter
properti
exosom
implic
alzheim
diseas
ad
fig
associ
process
alzheim
protein
enzym
trojan
exosom
model
alzheim
similar
concept
trojan
exosom
model
viral
infect
propos
initi
insult
alzheim
may
spread
surround
cell
via
exosom
laden
amyloid
beta
ab
peptid
protein
rna
associ
precipit
alzheim
pathogenesi
support
find
deposit
exosom
protein
amyloid
plaqu
ad
brain
final
exosom
also
associ
spread
prion
protein
indic
multipl
role
exosom
neurodegen
diseas
discuss
variou
physiolog
pathophysiolog
role
exosom
may
play
differ
cell
tissu
type
clear
mani
opportun
exist
har
exosom
biolog
either
therapeut
treatment
strategi
exampl
capac
differenti
challeng
dc
produc
dexosom
either
proor
antiinflammatori
properti
find
excit
use
field
cancer
vaccin
humor
immun
sar
sever
acut
respiratori
syndrom
vaccin
transplant
toler
induct
delay
type
hypersensit
respons
rheumatoid
fig
exosom
alter
molecular
profil
microenviron
recipi
cell
affect
tissu
health
exosom
help
establish
metastat
nich
aid
tumor
growth
tumor
metastasi
util
vegf
cytokin
cargo
exosom
enhanc
recruit
hematopoiet
endotheli
precursor
cell
enhanc
neoangiogenesi
tumor
exosom
also
suggest
influenc
planar
cell
polar
extracellular
matrix
allow
tumor
cell
mobil
aid
tumor
growth
exosom
addit
known
trigger
apoptot
reduct
antitumor
immun
cell
fasl
tnfpathway
growth
factor
cytokin
cargo
help
exosom
attract
dissemin
tumor
cell
primari
tumor
site
well
cell
myeloid
erythropoiet
lineag
premetastat
nich
aid
tumor
spread
b
exosom
share
mani
characterist
virus
molecular
machineri
bud
plasma
membran
retrovirus
like
hiv
util
cellencod
intercellular
vesicl
traffic
mean
protect
host
cell
proteolyt
system
segreg
exosom
exosom
format
event
viru
camouflag
avoid
host
surveil
system
proteolysi
exosom
encapsul
viru
furthermor
abl
dissemin
move
cell
util
exosom
pathway
enter
host
cell
without
util
fusion
machineri
search
optim
target
cell
exosom
thu
aid
transinfect
virus
c
amyloid
plaqu
alzheim
diseas
afflict
brain
aggreg
amyloid
beta
peptid
process
amyloid
precursor
protein
app
app
process
least
three
proteas
term
b
gsecretas
lead
gener
number
proteolyt
fragment
includ
ab
app
cleav
band
gsecretas
exosom
found
contain
app
ab
proteolyt
fragment
app
b
compon
gsecretas
also
suggest
exosom
unhealthi
brain
cell
may
caus
spread
cellular
insult
form
rna
protein
surround
healthi
cell
thu
aid
spread
neurolog
disord
ee
earli
endosom
aicd
amyloid
precursor
protein
intracellular
cytoplasmicctermin
domain
arthriti
treatment
etc
addit
studi
ongo
establish
exosom
nanocarri
deliveri
varieti
therapeut
modal
formal
possibl
although
current
unlik
target
exosom
releas
could
repres
viabl
therapeut
strategi
howev
futur
research
demonstr
exosom
critic
certain
patholog
diseas
process
strategi
target
format
andor
releas
exosom
specif
cell
type
eg
primari
tumor
cell
etc
would
repres
novel
rout
therapeut
intervent
design
strategi
specif
format
exosom
singl
cell
type
rather
creat
gener
exosom
poison
like
tantamount
tremend
challeng
develop
drug
specif
exosom
disrupt
would
critic
sinc
unlik
gener
shutdown
exosom
format
would
toler
without
advers
consequ
achiev
specif
destruct
modul
might
challeng
due
nonredund
natur
exosom
format
regul
difficulti
identifi
molecul
specif
requir
target
cellspecif
exosom
format
process
bodi
howev
believ
approach
ca
nt
rule
potenti
therapeut
strategi
year
come
innov
therapeut
modal
emerg
today
bi
trispecif
antibodi
etc
other
horizon
pharmacolog
approach
may
becom
feasibl
exosom
conclus
implic
diseas
futur
review
discuss
detail
stride
made
align
exosom
biolog
biomark
develop
aid
better
health
care
standard
term
exosomebas
applic
major
facet
exosom
biolog
find
util
usag
celland
conditionspecif
cargo
biomark
given
exosom
profil
reflect
cell
content
exosom
provid
mean
liquid
biopsi
minim
invas
highli
enlighten
tabl
summar
main
exosom
deriv
biomark
associ
differ
diseas
condit
cell
cultur
base
studi
emerg
field
still
rel
young
consid
vast
wealth
inform
emerg
regularli
new
exosom
content
exampl
discov
fairli
recent
exosom
contain
dna
repres
mitochondri
dna
well
retrotransposon
amplifi
dna
oncogen
tumor
cell
deriv
exosom
power
exosom
biomark
reli
enrich
marker
within
exosom
otherwis
constitut
small
proport
secretom
eg
exosom
protein
repres
less
total
plasma
proteom
healthi
human
circul
exosom
contain
protein
enrich
cell
traffick
protein
sort
relat
protein
reflect
endosom
origin
exosom
fig
highli
enrich
protein
entiti
plasma
urin
normal
dampen
minor
presenc
relev
biomark
exosom
biomark
strategi
therefor
truli
exemplifi
less
sinc
small
number
protein
rna
nevertheless
give
insight
inform
diseas
patholog
enrich
sourc
exemplifi
cargo
sort
exosom
help
discoveri
rel
lowli
express
biomark
normal
would
go
undetect
sever
studi
shown
purif
fluid
level
protein
rna
also
provid
biomark
tabl
author
suggest
practic
casebycas
base
scenario
sensit
provid
exosom
isol
may
crucial
certain
diagnost
biomark
differenti
may
high
enough
diseas
condit
isol
exosom
bypass
fluid
base
biomark
analysi
may
suffici
multitud
secretom
converg
bodi
fluid
varieti
cell
type
contribut
secretom
confound
fluidbas
analysi
system
exampl
plasma
exosom
normal
individu
origin
varieti
cell
sourc
includ
red
blood
cell
leukocyt
lineag
platelet
tissu
directli
indirectli
contact
blood
stream
endotheli
cell
larg
fenestr
organ
like
placenta
liver
also
allow
passag
exosom
vesicl
bodi
fluid
case
biomark
chang
indic
one
condit
exosom
would
method
choic
trace
cell
lineag
produc
chang
anoth
advantag
use
exosom
biomark
abil
immunoisol
exosom
particular
tissu
type
exosom
membran
reflect
cell
plasma
membran
therefor
immunoisol
util
significantli
enrich
protein
membran
surfac
exampl
plasma
exosom
hepat
origin
enrich
use
antibodi
specif
rel
liverspecif
enzym
carbamoyl
phosphat
synthetas
cell
cultur
affinityisol
colorect
cancer
cell
line
exosom
isol
jurkat
tcell
line
exosom
yield
specif
cell
base
signatur
hold
promis
appli
similarli
plasma
exosom
isol
studi
compar
ovarian
carcinoma
cell
line
deriv
exosom
vs
exosom
malign
ascit
sera
ovarian
carcinoma
patient
tumor
progressionrel
protein
like
cell
adhes
molecul
emmprin
extracellular
matrix
metalloproteinas
induc
found
enrich
exosom
studi
also
indic
exosom
becom
system
via
blood
stream
urinari
exosom
profil
studi
probabl
establish
greatest
detail
owe
easi
access
urin
sampl
semin
work
knepper
star
lab
establish
condit
collect
store
sampl
optim
design
mass
spectrometri
gel
chromatographi
base
techniqu
urinari
exosom
analysi
establish
urinari
exosom
contain
major
renal
protein
indic
renal
cell
injuri
includ
limit
aquaporin
polycystin
podocyn
success
studi
perform
variou
diseas
condit
cellular
contact
urin
glomerular
filtrat
would
possibl
eg
acut
kidney
injuri
aki
model
cisplatin
ischemiareperfus
prostat
cancer
bladder
cancer
etc
bladder
cancer
cell
line
deriv
exosom
contain
protein
also
found
urin
deriv
exosom
small
number
bladder
cancer
patient
urin
micro
particl
bladder
cancer
patient
reveal
eight
protein
elev
rel
control
mani
protein
link
epiderm
growth
factor
receptor
egfr
signal
pathway
exampl
suggest
exosom
biomark
discoveri
approach
topsid
topsid
initi
screen
condit
media
cultur
cell
line
use
build
predict
model
pathway
repres
exosom
model
translat
vivo
model
biolog
fluid
sampl
larg
patient
cohort
prostasom
exosom
releas
prostat
epithelium
semen
urin
analysi
urin
exosom
content
reveal
prostat
cancer
patient
tumor
signatur
eg
psa
prostat
specif
antigen
prostat
cancer
gene
cell
cultur
media
deriv
exosom
urin
prostasom
exhibit
enhanc
dcatenin
rotaviru
relat
gastroent
patient
display
exosom
associ
rv
antigen
stool
sampl
anim
model
kidney
injuri
exosom
fetuina
identifi
marker
reflect
nephrotox
damag
increas
healthi
anim
within
hour
injuri
prior
detect
standard
biomark
urin
creatinin
renal
ischemiareperfus
ir
decreas
exosom
rat
correl
decreas
level
person
undergo
renal
transplant
pilot
studi
bartter
syndrom
type
patient
sodiumpotassiumchlorid
cotransport
absent
urinari
exosom
addit
shown
zhou
et
al
transcript
factor
undetect
whole
urin
could
detect
urin
deriv
exosom
eg
urinari
cyclic
ampdepend
transcript
factor
might
novel
aki
renal
tubular
cell
injuri
biomark
wilm
tumor
protein
might
critic
biomark
chronic
kidney
diseas
ckd
associ
podocyt
injuri
noteworthi
current
biomark
perspect
ckd
clearli
unmet
need
consensu
predict
prognost
biomark
particularli
context
earli
detect
sensit
discuss
reflect
strength
exosom
fluidbas
minim
invas
biomark
also
identifi
need
larger
cohort
studi
well
establish
protocol
clinic
studi
studi
must
built
posit
neg
control
valid
studi
design
variou
step
sampl
collect
time
storag
process
well
protocol
protein
biomark
identif
base
western
blot
analysi
elisa
enzym
link
immunosorb
assay
fac
fluoresc
activ
cell
sort
analysi
context
rnabas
biomark
studi
date
rna
composit
human
urinari
exosom
repres
region
nephron
collect
duct
determin
rtpcr
signific
studi
specif
exosom
rna
biomark
urinari
exosom
vatpas
subunit
knockout
mice
found
faith
reflect
loss
specif
subunit
mrna
normal
amount
vatpas
subunit
aquaporin
detect
preliminari
studi
shown
salivari
exosom
protein
mirna
content
potenti
use
detect
diseas
condit
sjorgen
syndrom
increas
breast
tumor
level
reflect
system
circul
exosom
glioblastoma
deriv
exosom
contain
diagnost
set
mir
addit
mutant
egfr
viii
prostat
cancer
plasma
exosom
reveal
upregul
circul
level
decreas
cancer
patient
postop
suggest
feasibl
prognosi
biomark
well
studi
level
certain
mir
also
correl
well
clinicopatholog
variabl
like
nodal
statu
estrogen
receptor
statu
signific
chang
protein
mirna
also
report
circul
exosom
patient
suffer
ovarian
cancer
studi
found
set
mir
could
distinguish
benign
vs
malign
ovarian
tumor
peripher
blood
exosom
mir
show
profil
lung
adenocarcinoma
stage
iiv
patient
predict
capac
exosom
mirna
quit
outstand
exemplifi
two
exosom
mirna
accur
discrimin
acut
lymphoid
acut
myeloid
leukemia
author
propos
term
fluidom
captur
complex
secret
protein
lipid
rna
dna
compon
allow
insight
cellular
process
biofluid
cell
cultur
medium
level
term
rna
content
earliest
report
circul
rna
hypothes
bodi
fluid
deriv
rna
must
somehow
protect
degrad
rnaserich
content
bodi
fluid
mani
interest
theori
arisen
time
answer
conundrum
presenc
novel
conform
impart
resist
nucleas
confin
exosomelik
vesicl
recent
presenc
argonaut
bound
ldl
bound
rna
speci
plasma
fascin
question
field
exosom
biolog
includ
cargo
sort
mechan
exosom
uptak
specif
correl
mrna
mirna
protein
content
exosom
term
select
expuls
well
landscap
effect
recipi
cell
far
studi
focus
individu
biolog
exosom
dedic
effort
correl
effect
molecul
integr
result
cell
function
level
thu
obviou
basic
research
need
answer
outstand
question
exosom
biolog
strengthen
knowledg
base
field
conclus
continu
advanc
technolog
profil
exosom
content
high
throughput
manner
combin
elucid
basic
biolog
system
exosom
provid
novel
biomark
discoveri
therapeut
platform
great
promis
continu
basic
research
set
foundat
transit
exosomebas
diagnost
prognost
biomark
clinic
better
understand
molecular
mechan
diseas
pathogenesi
